Hostname: page-component-78c5997874-xbtfd Total loading time: 0 Render date: 2024-11-17T10:13:57.016Z Has data issue: false hasContentIssue false

Decision-making in older people with dementia

Published online by Cambridge University Press:  28 October 2013

M. Aurora Viloria Jiménez*
Affiliation:
Memory Unit of the Geriatric Department, Hospital Clinico San Carlos, Madrid, Spain Palliative Care Unit, Hospital Clinico San Carlos, Madrid, Spain
Mónica Chung Jaén
Affiliation:
Memory Unit of the Geriatric Department, Hospital Clinico San Carlos, Madrid, Spain
Marta Vigara García
Affiliation:
Memory Unit of the Geriatric Department, Hospital Clinico San Carlos, Madrid, Spain
Helena Barahona‐Alvarez
Affiliation:
Palliative Care Unit, Hospital Clinico San Carlos, Madrid, Spain
*
Address for correspondence: Dr Aurora Viloria Jiménez, Servicio de Geriatría, Hospital Clínico San Carlos, c/Profesor Martín Lagos s/n, Madrid 28040, Spain. Email: [email protected]

Summary

Dementia is a syndrome characterized by a progressive impairment in cognition, function and behaviour, with a considerable burden in terms of health and social care, and economic costs. As Alzheimer's disease and other dementias advance, the patient's capacity, competence and possibility of participation in decision-making decrease. Key points in managing people with dementia include screening of cognitive impairment, neuropsychological assessment, laboratory tests and neuroimaging, genetic tests, informed consent, inclusion in clinical trials and discussion of advance directives, driving, managing finances and testamentary capacity, pharmolocogical and non-pharmacological treatment and also palliative and end-of-life care. In this article we review these crucial points in decision-making for people with dementia and their families and caregivers.

Type
Review Article
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Reitz, C, Brayne, C, Mayeux, R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7: 137–52.CrossRefGoogle ScholarPubMed
2Howe, EG. Ethical issues in diagnosing and treating Alzheimer disease. Psychiatry 2006; 3: 4353.Google ScholarPubMed
3Page, K.The four principles: can they be measured and do they predict ethical decision making? BMC Med Ethics. 2012; 13: 1018.CrossRefGoogle ScholarPubMed
4Alvaro, LC.Competency: general principles and applicability in dementia. Neurologia 2012; 27: 290300.Google ScholarPubMed
5National Collaborating Centre for Mental Health. Dementia. A NICE-SCIE Guideline on Supporting People with Dementia and Their Carer in Health and Social Care. London: The British Psychological Society and Gaskell, 2007.Google Scholar
6Hamann, J, Bronner, K, Margull, Jet al.Patient participation in medical and social decisions in Alzheimer's disease. J Am Geriatr Soc 2011; 59: 2045–52.CrossRefGoogle ScholarPubMed
7Volicer, L, Ganzini, L. Health professionals’ views on standards for decision-making capacity regarding refusal of medical treatment in mild Alzheimer's disease. J Am Geriatr Soc 2003; 51: 1270–74.CrossRefGoogle ScholarPubMed
8Hirschman, KB, Joyce, CM, James, BD, Xie, SX, Karlawish, JH. Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them? Gerontologist 2005; 45: 381–88.CrossRefGoogle Scholar
9Galvin, JE, Fu, Q, Nguyen, JT, Glasheen, C, Scharff, DP. Psychosocial determinants of intention to screen for Alzheimer disease. Alzheimers Dement 2008; 4: 353–60.CrossRefGoogle Scholar
10Dale, W, Hemmerich, J, Hill, EK, Hougham, GW, Sachs, GA. What correlates with the intention to be tested for mild cognitive impairment (MCI) in healthy older adults? Alzheimer Dis Assoc Disord 2008; 22: 144–52.CrossRefGoogle ScholarPubMed
11Mattsson, N, Brax, D, Zetterberg, H. To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease. Int J Alzheimer's Disease 2010, article ID 841941, 1–4.CrossRefGoogle Scholar
12Carpenter, BD, Xiong, C, Porensky, EKet al.Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. J Am Geriatr Soc 2008; 56: 405–12.CrossRefGoogle ScholarPubMed
13Forlenza, OV, Diniz, BS, Gattaz, WF. Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med 2010; 8: 89102.CrossRefGoogle ScholarPubMed
14Clark, CM, Davatzikos, C, Borthakur, Aet al.Biomarkers for early detection of Alzheimer pathology. Neurosignals 2008; 16: 1118.CrossRefGoogle ScholarPubMed
15Yim, S.The ethics of informed consent in Alzheimer's disease research. Nat Rev Neurol 2012; 7: 410–14.Google Scholar
16Knebl, J, Patki, D. Recruitment of subjects into clinical trials for Alzheimer disease. J Am Osteopath Assoc 2010; 110 (suppl 8): S4349.Google ScholarPubMed
17Goldman, JS, Hahn, SE, Catania, JWet al.Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med 2011; 13: 597605.CrossRefGoogle ScholarPubMed
18Tischa, JM, Van der Cammen, TJ, Croes, EAet al.Genetic testing has no place as a routine diagnostic test in sporadic and familial cases of Alzheimer's disease. J Am Geriatric Soc 2004; 52: 2110–13.Google Scholar
19NICE technology appraisal guidance 217. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of NICE technology appraisal guidance 111). London, National Institute for Health and Clinical Excellence, 2011.Google Scholar
20Man-Son-Hing, M, Marshall, SC, Molnar, FJ, Wilson, KG. Systematic review of driving risk and the efficacy of compensatory strategies in person with dementia. J Am Geriatr Soc 2007; 55: 878–84.CrossRefGoogle Scholar
21Ott, BR, Anthony, D, Papandonatos, GDet al.Clinician assessment of the driving competence of patients with dementia. J Am Geriatr Soc 2005; 53: 829–33.CrossRefGoogle ScholarPubMed
22Griffith, HR, Belue, K, Sicola, A. Impairment financial abilities in mild cognitive impairment. A direct assessment approach. Neurology 2003; 60: 449–57.CrossRefGoogle ScholarPubMed
23Marson, DC, Martin, RC, Wadley, Vet al.Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer's disease. J Am Geriatr Soc 2009; 57: 806–14.CrossRefGoogle ScholarPubMed
24Goodman, C, Goodman, C, Evans, Cet al.End of life care for community dwelling older people with dementia: an integrated review. Int J Geriat Psychiatry 2010; 25: 329–37.CrossRefGoogle ScholarPubMed
25Garand, L, Garand, L, Dew, MA, Lingler, JH, DeKosky, ST. Incidence and predictors of advance care planning among persons with cognitive impairment. Am J Geriatr Psychiatry 2011; 19: 712–20.CrossRefGoogle ScholarPubMed
26Sachs, GA, Shega, JW, Cox-Haley, D. Barriers to excellent end-of-life care for patients with dementia. J Gen Intern Med 2004; 19: 1057–63.CrossRefGoogle ScholarPubMed
27Mahon, M, Sorrel, J. Palliative care for people with Alzheimer's disease. Nurs Philos 2008; 9: 110–20.CrossRefGoogle ScholarPubMed
28Torke, AM, Holtz, LR, Hui, Set al.Palliative care for patients with dementia: a National Survey. J Am Geriatr Soc 2010; 58: 2114–21.CrossRefGoogle ScholarPubMed
29Mitchell, SL, Black, BS, Ersek, Met al.Advanced dementia: state of the art and priorities for the next decade. Ann Intern Med 2012; 156: 4551.CrossRefGoogle ScholarPubMed
30Medical guidelines for determining prognosis in selected non-cancer diseases. The National Hospice Organization. Hosp J 1996; 11: 4763.Google Scholar
31Palecek, EJ, Teno, JM, Casarett, DJ, Hanson, LC, Rhodes, RL, Mitchell, SL.Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 2010; 58: 580–84.CrossRefGoogle Scholar
32The, AM, Pasman, R, Onwuteaka-Philipsen, B, Ribbe, M, van der Wal, G.Withholding the artificial administration of fluids and food from elderly patients with dementia: ethnographic study. BMJ 2002; 325:1326–29.CrossRefGoogle ScholarPubMed
33Fuchs-Lacelle, S, Hadjistavropoulos, T. Development and preliminary validation of the Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC). Pain Mang Nurs 2004; 5: 37–49.Google ScholarPubMed
34Warden, V, Hurley, AC, Volicer, L. Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir A 2003; 4: 915.CrossRefGoogle ScholarPubMed
35Givens, JL, Selby, K, Goldfeld, KS, Mitchell, SL. Hospital transfers of nursing home residents with advanced dementia. J Am Geriatr Soc 2012; 60: 905–9.CrossRefGoogle ScholarPubMed
36Chen, JH, Lamberg, JL, Chen, YCet al.Ocurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia. J Am Geriatr Soc 2006; 54: 290–95.CrossRefGoogle Scholar
37Jokinen, N, Janicki, MP, Keller, SM, McCallion, P, Force, LT. National Task Group on Intellectual Disabilities and Dementia Practices. Guidelines for Structuring Community Care and Supports for People with Intellectual Disabilities Affected by Dementia. J Policy Practice Intellectual Disabil 2013; 10: 124.CrossRefGoogle Scholar
38Olsen, ML, Swetz, KM, Mueller, PS. Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc 2010; 85: 949–54.CrossRefGoogle ScholarPubMed
39Kirk, TW, Mahon, MM, for the Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee. National Hospice and Palliative Care Organization (NHPCO) Position Statement and Commentary on the Use of Palliative Sedation in Imminently Dying Terminally Ill Patients. J Pain Symptom Management 2010; 39: 914–23.CrossRefGoogle ScholarPubMed